Taken together with the overall group-level results, the data indicate a consistent immune profile between CeAD patients with and without stroke, characterized by a tendency toward elevated CD4 + T cells and lower NKT-cell frequencies relative to healthy controls. This evidence concerns the gene CD4 and Stroke.